Biodesix Stock (NASDAQ: BDSX) stock price, news, charts, stock research, profile.
Open | $1.280 |
Close | - |
Volume / Avg. | 430.000 / 160.559K |
Day Range | 1.260 - 1.280 |
52 Wk Range | 1.030 - 2.210 |
Market Cap | $145.067M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 0.42% |
Days to Cover | 5.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: GeneDx Hldgs (NASDAQ:WGS), Prenetics Global (NASDAQ:PRE), Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN) and ATI Physical Therapy (NYSE:ATIP).
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Canaccord Genuity on Monday, March 4, 2024. The analyst firm set a price target for 3.50 expecting BDSX to rise to within 12 months (a possible 175.85% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $1.2688 last updated April 16, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Biodesix.
Biodesix’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.